Enable Medicine Stock
Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.
Sign up today and learn more about Enable Medicine Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Enable Medicine Stock
Enable Medicine is a biotechnology company that accelerates insight discovery by generating, managing, and analyzing spatial biology data on the enable cloud platform. Run experiments, decrease costs, and accelerate time to insight. The Enable Cloud Platform provides a collaborative ecosystem and tools for generating, visualizing, and analyzing many biological image formats. Enable Medicine was established in 2019 by Aaron Mayer and Sunil Bodapati in Menlo Park, California.
Investors
Anthos Capital
goPuff, ConsenSys, Machine Zone, ApplyBoard, Front, Munchery, Enable Medicine
Funding History
| August 2020 | $3.6M |
|---|---|
| April 2022 | $60.0M |
Management
Co-Founder and CEO
Sunil Bodapati
Co-founder, CSO
Aaron Mayer
Press
mass-spec-capital - Apr, 15 2024
Enable Medicine. (2/13/24). "Press Release: Enable Medicine Appoints Kamni Vijay as Chief Executive Officer". Menlo Park, CA.businesswire - Apr, 8 2024
Enable Medicine Appoints Kamni Vijay as Chief Executive Officerbusinesswire - Apr, 8 2024
Enable Medicine Announces Publication in Science Immunology Showing Spatial Transcriptomics Reveal Distinct ...biospace - Feb, 13 2024
Enable Medicine Appoints Kamni Vijay as Chief Executive Officerwsj - Jan, 19 2024
Startups Are Using AI to Predict Responses to Cancer DrugsEquityZen Recognized As:
